The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Diffuse Alveolar Hemorrhage and Systemic Lupus Erythematosus: Clinical Presentation, Histology, Survival, and Outcome
Abstract
Diffuse alveolar hemorrhage (DAH) complicating systemic lupus erythematosus (SLE) remains a devastating pulmonary complication of this systemic disease. We conducted this study to review the clinicopathologic presentation and the effects of prior treatment, presence of infection, and current treatment on the survival and outcome of patients with DAH and SLE. We reviewed the records of 15 SLE patients who experienced 19 episodes of DAH over a 10-year period in a single tertiary care hospital. These patients were compared with 57 previously reported cases. The 19 episodes of DAH represented 3.7% of the 510 admissions occasioned by various complications of SLE. As previously reported, the majority (66%) were women with a median age of 27 years. The onset was often abrupt: < 3 days in 12 of the episodes. In 3 patients (20%), DAH was the initial manifestation of SLE, compared with 11% in the literature series. In the other patients in the present series, DAH appeared a median of 31 months following the diagnosis of SLE, versus 35 months in the literature series. In only 42% of the episodes in the present series, compared with 66% in the literature series, was hemoptysis present at the time of admission. However, hemoptysis eventually appeared in all 19 episodes. Temperature elevation (> 38 degrees C) was another inconsistent finding, found in only 5 episodes (26%) in the present series. The most constant concurrent systemic finding was lupus nephritis (14/15 patients). This represents a significant increase when compared with the literature series (29/48 patients). In 8 of 10 patients in whom lung tissue was available, pulmonary capillaritis accompanied the DAH. This represents a marked difference in the underlying histologic pattern when compared with the literature series. In those patients, 72% (31/43 patients) had bland pulmonary hemorrhage, and capillaritis was described in only 6 patients. The overall patient mortality rate was 53% in the current series and 50% in the literature series. Factors associated with an increased mortality in the present series include the following: mechanical ventilation (62%) versus no mechanical ventilation (0%); infection (78%) versus no infection (20%); and cyclophosphamide therapy for the acute DAH episode (70%) versus no cyclophosphamide therapy (20%). The incidence of infection in DAH and SLE (9/19 episodes) is far greater than previously reported (7/ 57 episodes). One possible explanation for this difference is the increased use of outpatient immunosuppressive therapy with monthly intravenous cyclophosphamide therapy for lupus nephritis. Eighteen DAH episodes in the present series were treated with intravenous methylprednisolone. When one combines both the current and literature series experience (16 episodes), the use of plasmapheresis does not improve survival. Of the 7 patients in the present series who survived all episodes of DAH, 6 remain alive a median of 50 months post episode and without recurrence of DAH. Diffuse alveolar hemorrhage is an uncommon but lethal complication of SLE. The survival rate remains unchanged from previous reports. The absence of hemoptysis should not exclude this diagnosis, particularly in those patients who experience an acute pulmonary syndrome with new radiographic infiltrates accompanied by falling hematocrit and the presence of a hemorrhagic bronchoalveolar lavage. Evidence for lupus nephritis is present in the great majority of cases. Most cases demonstrate the histologic pattern of pulmonary capillaritis. The mortality is adversely affected by the need for mechanical ventilation, either the presence of infection at the time of admission or the development of infection in the hospital, and the use of cyclophosphamide for treatment of the acute event.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
ALARCÓN-SEGOVIA, D., DELEZÉ, M., ORIA, C. V., SÁNCHEZ-GUERRERO, J., GÓMEZ-PACHECO, L., CABIEDES, J., FERNÁNDEZ, L., & DE LEÓN, S. P. (1989) · Medicine · doi:10.1097/00005792-198911000-00003 · Cited by 639
A Controlled Trial of Plasmapheresis Therapy in Severe Lupus Nephritis
Lewis, E. J., Hunsicker, L. G., Lan, S.-P., Rohde, R. D., & Lachin, J. M. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205213262101 · Cited by 473
Association between Hepatitis B Virus and Essential Mixed Cryoglobulinemia
Levo, Y., Gorevic, P. D., Kassab, H. J., Zucker‐Franklin, D., & Franklin, E. C. (1977) · New England Journal of Medicine · doi:10.1056/nejm197706302962605 · Cited by 405
MATTHAY, R. A., SCHWARZ, M. I., PETTY, T. L., STANFORD, R. E., GUPTA, R. C., SAHN, S. A., & STEIGERWALD, J. C. (1975) · Medicine · doi:10.1097/00005792-197509000-00003 · Cited by 345
Self-citationA Clinicopathologic Study of 34 Cases of Diffuse Pulmonary Hemorrhage with Lung Biopsy Confirmation
Travis, W. D., Colby, T. V., Lombard, C. M., et al. (1990) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199012000-00003 · Cited by 313
VASCULITIS WITH HEPATITIS B ANTIGENEMIA: Long-term Observations in Nine Patients
SERGENT, J. S., LOCKSHIN, M. D., CHRISTIAN, C. L., & GOCKE, D. J. (1976) · Medicine · doi:10.1097/00005792-197601000-00001 · Cited by 278
The lung in systemic lupus erythematosus
Haupt, H. M., Moore, G. W., & Hutchins, G. M. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90366-1 · Cited by 271
Leatherman, J. W., Davies, S. F., & Hoidal, J. R. (1984) · PubMed · Cited by 245
LEATHERMAN, J. W., DAVIES, S. F., & HOIDAL, J. R. (1984) · Medicine · doi:10.1097/00005792-198411000-00002 · Cited by 211
Cited by
Lara, A. R., & Schwarz, M. I. (2010) · Chest · doi:10.1378/chest.08-2084 · Cited by 530
Self-citationRare diseases bullet 7: Pleuropulmonary manifestations of systemic lupus erythematosus
Keane, M. P. (2000) · Thorax · doi:10.1136/thorax.55.2.159 · Cited by 276
Pego‐Reigosa, J. M., Cobo‐Ibáñez, T., Calvo‐Alén, J., Loza‐Santamaría, E., Rahman, A., Muñoz‐Fernández, S., & Rúa‐Figueroa, Í. (2013) · Arthritis Care & Research · doi:10.1002/acr.22035 · Cited by 74
Metadata
- Authors
- Zamora, M. R., Warner, M. L., Tuder, R., & Schwarz, M. I.
- Venue
- Medicine
- Published
- 1997-05
- Volume
- 76
- Issue
- 3
- Pages
- 192-202
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2026355082
- Cited by
- 478
- References
- 16
- FWCI
- 6.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Diffuse Alveolar Hemorrhage and Systemic Lupus Erythematosus: Clinical Presentation, Histology, Survival, and Outcome. https://app.cochat.ai/papers/10.1097/00005792-199705000-00005
- The paper
- Zamora, M. R., Warner, M. L., Tuder, R., & Schwarz, M. I. (1997). Diffuse Alveolar Hemorrhage and Systemic Lupus Erythematosus: Clinical Presentation, Histology, Survival, and Outcome. Medicine. https://doi.org/10.1097/00005792-199705000-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.